Sorafenib in Combination With Cytarabine and Clofarabine in Patients With Refractory or Relapsed Hematologic Malignancies

NCT00908167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Infantile Leukemia (Both AML and ALL)
Myelodysplastic Syndrome
Myelodysplastic/Myeloproliferative Neoplasms
Biphenotypic Leukemia

Interventions

DRUG: Sorafenib
DRUG: Cytarabine
DRUG: Clofarabine

Sponsor

St. Jude Children's Research Hospital

Collaborators

[object Object]
[object Object]